Abstract
Twelve patients receiving Buserelin and seven patients receiving danazol for treatment of endometriosis were studied to assess the effect of medication on plasma lipoproteins. Danazol significantly lowered plasma HDL-C levels at 6 months of treatment. Total plasma cholesterol was elevated at 6 months of therapy in the Buserelin group. No effect by either drug on plasma triglycerides was seen.
Publication types
-
Comparative Study
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adult
-
Buserelin / therapeutic use*
-
Cholesterol / blood
-
Cholesterol, HDL / blood
-
Cholesterol, LDL / blood
-
Danazol / therapeutic use*
-
Endometriosis / blood
-
Endometriosis / drug therapy*
-
Female
-
Humans
-
Lipoproteins / blood*
-
Pregnadienes / therapeutic use*
Substances
-
Cholesterol, HDL
-
Cholesterol, LDL
-
Lipoproteins
-
Pregnadienes
-
Cholesterol
-
Danazol
-
Buserelin